nCino (NCNO – Research Report) received a Buy rating and price target from Truist Financial analyst Terry Tillman today. The company’s shares closed last Friday at $32.57. According to ...

Sanofi has tapped Alloy Therapeutics to enable development of a central nervous system drug, agreeing to pay $27.5 million in upfront and near-term fees to access an antisense platform.

Construction of the expansion at the Rosemount, Minnesota, campus of secondary aluminum foundry Spectro Alloys, has been completed after breaking ground on the project in March of last year. The ...

I am downgrading nCino, Inc. to a hold rating due to macroeconomic pressures and heightened competition impacting growth prospects. The higher-for-longer interest rate environment is negatively ...

Pierre Naudé Appointed Executive Chairman of the Board Sean Desmond nCino Announces Appointment of Sean Desmond as President and Chief Executive Officer WILMINGTON, N.C., Feb. 03, 2025 (GLOBE ...

One stock with a strong underlying earnings trend is today’s Bull of the Day, nCino (NCNO). nCino is a software-as-a-service company, provides cloud-based software applications to financial ...

Shares of nCino (NCNO) have gained 0.6% over the past four weeks to close the last trading session at $33.76, but there could still be a solid upside left in the stock if short-term price targets ...

Shares of nCino (NCNO) have been struggling lately and have lost 8.3% over the past four weeks. However, a hammer chart pattern was formed in its last trading session, which could mean that the ...